The country has reported more than 28,000 cases of the rare fungal infection, now increasingly seen in COVID-19 patients and survivors. More than 85% of the reported cases of mucormycosis, which has a high mortality rate, have a history of COVID-19, India's Health Minister Dr. Harsh Vardhan said last week.